A Systematic Review of Safety and Efficacy of Factor XI/XIa Inhibitors in Patients With ESKD on Hemodialysis.

Kidney Int Rep · 2025 · PMC11725973 · PMID 39810768

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

46 , 47 , 48 Both thromboembolic events and all-cause mortality were numerically lower in patients receiving FXI/XIa inhibitors; however, this reduction did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.